APT College Seminars Series
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Psychiatric Bulletin All RCPsych Journals
 QUICK SEARCH:   [advanced]


     


Advances in Psychiatric Treatment (2008) 14: 283-284. doi: 10.1192/apt.bp.107.004762
© 2008 The Royal College of Psychiatrists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in APT
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Farmer, A. E.
PubMed
Right arrow Articles by Farmer, A. E.

Confidentiality in Munchausen’s syndrome

INVITED COMMENTARY ON... Neuropathica diabolica{dagger}

Anne E. Farmer

Anne Farmer is Professor of Psychiatric Nosology at the Institute of Psychiatry, London (Social, Genetic & Developmental Psychiatry, Research Centre, Institute of Psychiatry, London SE5 8AF, UK. Email: a.farmer{at}iop.kcl.ac.uk). She has had a number of research interests over the years, and is currently focusing on genetic research in affective disorders. In addition, she is lead consultant in the Affective Disorders Unit at the South London and Maudsley NHS Foundation Trust, where she runs a tertiary referral service for hard-to-treat patients with affective disorders as well as a special service for healthcare professionals.

This commentary questions whether the usual ethical and legal requirements for maintaining confidentiality of individuals who fabricate illness should be breached in order to prevent further harm to themselves as well as cost to society. A case report of an individual with Munchausen’s syndrome submitted for publication in Advances in Psychiatric Treatment provoked considerable Editorial discussion regarding the absence of written informed consent from the individual described. It is hoped that this commentary will widen the debate regarding the requirement for confidentiality in the exceptional circumstances of patients with Munchausen’s syndrome.



Related articles in APT:

Neuropathica diabolica
Julius Bourke and Benjamin Turner
APT 2008 14: 276-282. [Abstract] [Full Text]  






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Psychiatric Bulletin All RCPsych Journals
Copyright © 2008 The Royal College of Psychiatrists.